- Report
- September 2024
- 80 Pages
France
From €3108EUR$3,500USD£2,715GBP
- Report
- September 2024
- 80 Pages
Japan
From €3108EUR$3,500USD£2,715GBP
- Report
- August 2024
- 80 Pages
Japan
From €3108EUR$3,500USD£2,715GBP
- Report
- June 2024
- 183 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- April 2024
- 185 Pages
Global
From €3996EUR$4,500USD£3,491GBP
- Report
- October 2023
- 133 Pages
Europe
From €3552EUR$4,000USD£3,103GBP
- Report
- October 2023
- 138 Pages
Asia Pacific
From €3552EUR$4,000USD£3,103GBP
- Report
- July 2024
- 125 Pages
United Kingdom
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 139 Pages
United States
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 134 Pages
Germany
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 133 Pages
Russia
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 131 Pages
China
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 138 Pages
Japan
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 124 Pages
Saudi Arabia
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 136 Pages
Turkey
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 128 Pages
Canada
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 140 Pages
France
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 138 Pages
Brazil
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 128 Pages
Italy
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP
- Report
- July 2024
- 133 Pages
Spain
From €2264EUR$2,549USD£1,978GBP
€2663EUR$2,999USD£2,327GBP

The insulin market is a subset of the larger endocrine and metabolic disorders drugs market. Insulin is a hormone produced by the pancreas that helps regulate the body's blood sugar levels. It is used to treat diabetes, a condition in which the body does not produce enough insulin or is unable to use it effectively. Insulin is available in both short-acting and long-acting forms, and is typically administered via injection or an insulin pump.
The insulin market is highly competitive, with a number of major pharmaceutical companies offering a variety of insulin products. These include Eli Lilly, Novo Nordisk, Sanofi, and Merck. Additionally, there are a number of smaller companies that specialize in the production of insulin, such as Biocon, Wockhardt, and Wockhardt USA. Show Less Read more